Free Trial

AbbVie (ABBV) Dividend Yield, Date & History

$194.19
-0.16 (-0.08%)
(As of 10/11/2024 ET)

Dividend Summary

Dividend Yield
3.19%
Annual Dividend
$6.20
Dividend Increase
Track Record
52 Years
Annualized 3-Year
Dividend Growth
7.84%
Dividend Payout Ratio
183.98%
Next
Dividend Payment
Nov. 15
Skip Charts & View Dividend History

ABBV Dividend Yield Over Time

AbbVie vs. The Competition

TypeAbbVieMedical CompaniesNYSE Companies
Annual Dividend$6.20$6.10$1.48
Dividend Yield3.19%440.66%349.39%
Annualized 3-Year Dividend Growth7.84%16.25%15.74%
Track Record52 years21 years23 years

AbbVie Dividend Payout Ratio

TypePayout Ratio
Based on Trailing 12 Months of Earnings183.98%
Based on This Year's Estimates57.14%
Based on Next Year's Estimates51.20%
Based on Cashflow39.30%

AbbVie Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/6/2024quarterly$1.553.21%10/15/202410/15/202411/15/2024
6/20/2024quarterly$1.553.6%7/15/20247/15/20248/15/2024
2/15/2024quarterly$1.553.54%4/12/20244/15/20245/15/2024
10/27/2023Quarterly$1.554.46%1/12/20241/16/20242/15/2024
9/8/2023quarterly$1.483.98%10/12/202310/13/202311/15/2023
6/22/2023quarterly$1.484.31%7/13/20237/14/20238/15/2023
2/16/2023quarterly$1.483.96%4/13/20234/14/20235/15/2023
10/28/2022Quarterly$1.484.01%1/12/20231/13/20232/15/2023
9/9/2022quarterly$1.413.98%10/13/202210/14/202211/15/2022
6/23/2022quarterly$1.413.77%7/14/20227/15/20228/15/2022
2/17/2022quarterly$1.413.89%4/13/20224/15/20225/16/2022
10/29/2021quarterly$1.415.14%1/13/20221/14/20222/15/2022
9/10/2021quarterly$1.304.88%10/14/202110/15/202111/15/2021
6/17/2021quarterly$1.304.53%7/14/20217/15/20218/16/2021
2/18/2021quarterly$1.304.9%4/14/20214/15/20215/14/2021
10/30/2020quarterly$1.306.45%1/14/20211/15/20212/16/2021
9/11/2020quarterly$1.185.25%10/14/202010/15/202011/16/2020
6/17/2020quarterly$1.184.9%7/14/20207/15/20208/14/2020
2/20/2020quarterly$1.185.02%4/14/20204/15/20205/15/2020
11/1/2019--$1.185.93%1/14/20201/15/20202/14/2020
9/9/2019--$1.076.4%10/11/201910/15/201911/15/2019
6/20/2019Quarterly$1.075.43%7/12/20197/15/20198/15/2019
2/21/2019quarterly$1.075.45%4/12/20194/15/20195/15/2019
11/5/2018quarterly$1.075.18%1/14/20191/15/20192/15/2019
9/7/2018quarterly$0.964.09%10/12/201810/15/201811/15/2018
6/14/2018quarterly$0.963.89%7/12/20187/13/20188/15/2018
2/15/2018quarterly$0.963.36252189141856%4/12/20184/13/20185/15/2018
10/27/2017Quarterly$0.713.12%1/11/20181/12/20182/15/2018
9/8/2017Quarterly$0.642.94%10/12/201710/13/201711/15/2017
6/23/2017quarterly$0.643.52%7/12/20177/14/20178/15/2017
2/17/2017quarterly$0.644.14%4/11/20174/13/20175/15/2017
10/28/2016quarterly$0.644.44%1/11/20171/13/20172/15/2017
9/12/2016quarterly$0.573.56%10/12/201610/14/201611/15/2016
6/17/2016quarterly$0.573.8%7/13/20167/15/20168/15/2016
2/19/2016quarterly$0.574.2%4/13/20164/15/20165/16/2016
11/2/2015quarterly$0.573.6%1/13/20161/15/20162/16/2016
9/14/2015quarterly$0.513.46%10/13/201510/15/201511/14/2015
6/19/2015quarterly$0.512.94%7/13/20157/15/20158/14/2015
2/20/2015quarterly$0.513.33%4/13/20154/15/20155/15/2015
10/20/2014quarterly$0.493.48%1/13/20151/15/20152/13/2015
Bill Gates’s Next Big AI Bet: Stargate (Ad)

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate
9/19/2014quarterly$0.422.86%10/10/201410/15/201411/17/2014
6/19/2014quarterly$0.423.15%7/11/20147/15/20148/15/2014
2/20/2014quarterly$0.423.29%4/11/20144/15/20145/15/2014
12/12/2013quarterly$0.403.06%1/13/20141/15/20142/14/2014
9/19/2013quarterly$0.403.34%10/10/201310/15/201311/15/2013
6/20/2013quarterly$0.403.75%7/11/20137/15/20138/15/2013
2/15/2013quarterly$0.404.19%4/11/20134/15/20135/15/2013
1/4/2013quarterly$0.401/15/20132/15/2013
1/7/2013special$0.401/11/20131/15/20132/15/2013
1/1/1900Quarterly$1.185.33%1/14/20201/1/19001/1/1900
(Data available from 1/1/2013 forward)

AbbVie Dividend - Frequently Asked Questions

What is AbbVie's dividend yield?

The current dividend yield for AbbVie is 3.19%. Learn more on ABBV's dividend yield history.

How much is AbbVie's annual dividend?

The annual dividend for ABBV shares is $6.20. Learn more on ABBV's annual dividend history.

How often does AbbVie pay dividends?

AbbVie pays quarterly dividends to shareholders.

When is AbbVie's next dividend payment?

AbbVie's next quarterly dividend payment of $1.55 per share will be made to shareholders on Friday, November 15, 2024.

When was AbbVie's most recent dividend payment?

AbbVie's most recent quarterly dividend payment of $1.55 per share was made to shareholders on Thursday, August 15, 2024.

When is AbbVie's ex-dividend date?

AbbVie's next ex-dividend date is Tuesday, October 15, 2024.

When was AbbVie's most recent ex-dividend date?

AbbVie's most recent ex-dividend date was Monday, July 15, 2024.

Is AbbVie's dividend growing?

Over the past three years, the company's dividend has grown by an average of 7.84% per year.

What track record does AbbVie have of raising its dividend?

AbbVie has increased its dividend for the past 52 consecutive years.

When did AbbVie last increase or decrease its dividend?

The most recent change in the company's dividend was an increase of $0.07 on Friday, October 27, 2023.

What is AbbVie's dividend payout ratio?
The dividend payout ratio for ABBV is:
  • 183.98% based on the trailing year of earnings
  • 57.14% based on this year's estimates
  • 51.20% based on next year's estimates
  • 39.30% based on cash flow
Is AbbVie a good dividend stock?

AbbVie's dividend yield of 3.18% is lower than the average Medical company that issues a dividend. The company's 52 consecutive years of dividend growth indicate that the company has a strong committment to maintain and grow its dividend. AbbVie's dividend payout ratio of 183.98% may not be sustainable. However, based on earnings estimates, ABBV will have a more sustainable dividend payout ratio of 51.20% next year.


This page (NYSE:ABBV) was last updated on 10/12/2024 by MarketBeat.com Staff
From Our Partners